{"id":23853,"date":"2026-06-20T22:34:00","date_gmt":"2026-06-20T20:34:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=8c8f7276fd6bf25c21c09a510ffa0472"},"modified":"2026-06-20T22:34:00","modified_gmt":"2026-06-20T20:34:00","slug":"nvcr-investors-have-opportunity-to-join-novocure-limited-fraud-investigation-with-the-schall-law-firm","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=23853","title":{"rendered":"NVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm"},"content":{"rendered":"

LOS ANGELES--(BUSINESS WIRE)--$NVCR<\/a>--The Schall Law Firm<\/a>, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NovoCure Limited (\u201cNovoCure\u201d or \u201cthe Company\u201d) (NASDAQ: NVCR<\/a>) for violations of the securities laws.<\/p><\/a><\/a>

\nThe investigation focuses on whether the Company issued false and\/or misleading statements and\/or failed to disclose information pertinent to investors. NovoCure touted the benefits of starting Tumor Treating Fields (\u201cTTFields\u201d) therapy earlier in the treatment cycle durings earnings calls and healthcare conference. But the Company\u2019s Phase 3 TRIDENT trial failed to find a statistically significant improvement with this approach, causing NovoCure shares to fall 20% on Juny 18, 2026.<\/p>

\nIf you are a shareholder who suffered a loss, click here to participate<\/a>.<\/p>

\nWe also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com<\/a>, or by email at bschall@schallfirm.com<\/a>.<\/p>

\nThe Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p> Contacts<\/b>

\nThe Schall Law Firm\nBrian Schall, Esq.\n310-301-3335\ninfo@schallfirm.com<\/a>www.schallfirm.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–$NVCR–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of NovoCure Limited (\u201cNovoCure\u201d or \u201cthe Company\u201d) (NASDAQ: NVCR) for violations of…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-23853","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/23853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23853"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/23853\/revisions"}],"predecessor-version":[{"id":23854,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/23853\/revisions\/23854"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}